5-Amino-1MQ (5-amino-1-methylquinolinium) is a small-molecule inhibitor of nicotinamide N-methyltransferase (NNMT); it is not a peptide. Preclinical research has examined NNMT inhibition in cellular energy metabolism and metabolic models.
Research areas
NNMT enzyme inhibition.
NAD-related and methyl-donor metabolic pathways.
Preclinical metabolic research.
Evidence context
The published evidence is predominantly preclinical. Findings from cells and animal models should not be treated as established human outcomes.
For research purposes only. Not intended for human consumption, self-administration or use as a medicine.
